Thyrotropin alfa

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Funders: European Commission and 1 more
  • Human trial1

Outcomes

3

Cortisol

downin humans1

1 study
  1. Thyrotropin alfa decreases cortisol in humans (-14.8% (SEM = 3.6%, p < 0.001)).

    “cortisol (-14.8% [SEM = 3.6%, p < 0.001] and -15.6% [SEM = 3.5%, p < 0.001])”

    Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29

    Effect of Thyroid Status Modulation on Pituitary and Peripheral Hormone Concentrations in Healthy Older Subjects

    NeuroendocrinologyDec 3, 2024

More on Cortisol

Prolactin

downin humans1

1 study
  1. Thyrotropin alfa decreases prolactin in humans (-8.8% (SEM = 3.4%, p = 0.048)).

    “prolactin significantly decreased in both rhTSH and T3 challenges (-8.8% [SEM = 3.4%, p = 0.048] and -12.0% [3.3%, p = 0.004], respectively)”

    Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29

    Effect of Thyroid Status Modulation on Pituitary and Peripheral Hormone Concentrations in Healthy Older Subjects

    NeuroendocrinologyDec 3, 2024

More on Prolactin

IGF-1

upin humans1

1 study
  1. Thyrotropin alfa increases IGF-1 in humans (+6.3% (SEM = 1.6%, p = 0.002)).

    “IGF-1 increased with a maximum of 6.3% (SEM = 1.6%, p = 0.002) in the rhTSH challenge”

    Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29

    Effect of Thyroid Status Modulation on Pituitary and Peripheral Hormone Concentrations in Healthy Older Subjects

    NeuroendocrinologyDec 3, 2024

More on IGF-1

Latest